Shorts

The Case for Expanding MS Clinical Trial Eligibility

Overviewing ISSCR's New Course on Parkinson Disease and Stem Cell Medicine

CMSC 2026: The Patient Journey of Living With MS

Are MS Trial Categories Outdated?

CMSC 2026: Misconceptions on Stopping DMTs in Multiple Sclerosis

CMSC 2026: 3 Myths About Pregnancies and MS

Rethinking the MS Clinical Trial Process

How Self-Motivation and Consistency Support Long-Term Wellness

AMDAPP Series: Overviewing Austedo for Movement Disorders

CMSC 2026: OCT in the 2024 McDonald Criteria

Questions Patients Should Ask During Diagnostic Workup for Essential Tremor

Can You Regain Lost Sleep?

High Efficacy Treatment Crucial in MS Care

Implementing Zeto One EEG Headset Into Clinical Care Settings

RECAP: Neurology News Network - May 23rd

AMDAPP Series: Clinical Use of Onapgo to Treat Parkinson Disease

How Investigational Tavapadon Changes the Parkinson Disease Treatment Landscape

Acting Tremor vs Rest Tremor

AMDAPP Series: Understanding Vyalev Pump Therapy for Parkinson Disease

AAN 2026: Using OCT in Pediatric Multiple Sclerosis

Overviewing 3-Year Data of Huntington Agent AMT-130

Clinical Red Flags Prompting Early Evaluation for CNS Involvement in Cancer Patients

AAN 2026: Phase 3 NIMBLE Study of Cemdisiran in MG

AMDAPP Series: Overviewing Duopa Therapy for Parkinson Disease

Early Diagnosis, Patient Education Key in Alexander Disease Care

Functionality of Newly Cleared Cala kIQ Plus Wearable for Essential Tremor and Parkinson Disease

Stroke Awareness Month: Expanding the Imaging-Guided Thrombolysis Window

Phase 3 INVEST-HD Trial of Votoplam in Huntington Disease

Tavapadon, Dopamine Agonists, and the Expansion of Parkinson Treatment Options

RECAP: Neurology News Network - May 9th